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The twitcher mouse is a murine model of globoid cell
leukodystropy, a genetic demyelinating disease
caused by a mutation of the galactosylceramidase
gene. Demyelination of the central nervous system
commences around 20 postnatal days. Using GFP-
transgenic mice as donors, the distribution of hema-
togenous cells after bone marrow transplantation was
investigated in the twitcher mice. Bone marrow trans-
plantation was carried out at 8 postnatal days. In
twitcher chimeric mice examined before 30 postnatal
days, numerous GFP1 cells were detected in spleen
and peripheral nerve but only a few were detected in
the liver, lung, and spinal white matter. In contrast,
at 35 to 40 postnatal days when demyelination is
evident, many GFP1 cells with ameboid form were
detected in the white matter of the spinal cord, brain-
stem, and cerebrum. Approximately half of these
GFP1 cells were co-labeled with Mac-1. In twitcher
chimeric mice examined after 100 postnatal days, the
majority of GFP/Mac-1 double-positive cells displayed
the morphological features of ramified microglia with
fine delicate processes and was distributed diffusely
in both gray and white matter. These results suggest
that a significant number of donor hematogenous
cells are able to infiltrate into the brain parenchyma,
repositioning themselves into areas previously occu-
pied by microglia, and to ameliorate lethality. (Am J
Pathol 2000, 156:1849–1854)
Bone marrow transplantation (BMT) has been carried out
as a potential treatment for lysosomal storage disorders
in humans1–4 and in animal models.5–15 In many of these
disorders, the effectiveness of the BMT treatment is often
limited to the visceral organs, with little improvement in
the central nervous system (CNS).1,13 However, BMT has
been reported to ameliorate clinical course and patho-
logical process of the lysosomal storage diseases affect-
ing the white matter.3,4 In the previous BMT study using
the twitcher mouse, a murine model of globoid cell leu-
kodystrophy (GLD), we have detected donor-derived
cells in the central nervous system5 in mice that were
significantly improved clinically as well as pathological-
ly.16,17 An activity of the galactosylceramidase, the en-
zyme deficient in GLD,18 was elevated in the brains of the
twitcher that received BMT.5 More recently, we have
observed that, after the injection of the fluorescent dye
rhodamine isothiocyanate into the peritoneal cavity, mas-
sive infiltration of rhodamine-labeled peripheral mono-
cytes/macrophages were detected in the CNS of nonir-
radiated twitcher mice along with progression of the
demyelination (Y-P Wu, J Matsuda, A Kubota, K Suzuki,
and K Suzuki, unpublished observation). These findings
are consistent with the hypothesis that in lysosomal dis-
eases affecting the white matter, peripheral hematoge-
nous lineage cells infiltrate into the CNS and peripheral
nervous system as a natural disease process.
In this report, we describe the time course and distri-
bution of the infiltrated donor hematogenous cells, and
their morphological transformation into microglia in the
twitcher mice that received BMT from GFP transgenic
mice with normal galactosylceramidase activity.
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Materials and Methods
Generation of GFP-Transgenic Mice (C57BL/6-
H-2KbP-EGFP)
The transgene was engineered by subcloning the entire
H-2Kb promoter region (1960 bp) into SalI and BamHI
restriction sites found upstream of a variant GFP (EGFP)
gene encoded by pEGFP-1 (Clontech, Palo Alto, CA).
The EGFP gene encodes a protein with a single red-
shifted excitation peak and fluoresces 30- to 40-fold more
intensely than wild-type GFP when excited at 488 nm.
Expression of the H-2KbP-EGFP recombinant was veri-
fied by transfection into EL-4 cells. A SalI-ClaI 3000-bp
fragment was isolated and microinjected into C57BL/6
derived embryos. Integration of the transgene was ini-
tially determined by Southern blotting of genomic tail
DNA with a GFP-specific probe, and subsequently con-
firmed by flow cytometry analysis of peripheral lympho-
cytes prepared from founder mice.
Identification of Twitcher Mice
The original breeder pairs were obtained from the Jack-
son Laboratory (Bar Harbor, ME) and the colony has
been maintained in our institution. The genotypes of
twitcher (GALCtwi/twi) on the C57BL/6 (B6) background and
wild-type littermate (GALC1/1) mice were identified by
polymerase chain reaction using genomic DNA from the
clipped tail on postnatal days 5 to 6.19
Bone Marrow Transplantation
Either sex-matched adult GFP-transgenic mice (C57BL/
6-H-2KbP-EGFP) or wild-type C57BL/6 mice were used
as donors. The BMT was carried out in twitcher and
wild-type littermate control mice at 8 postnatal days or in
5-week-old adult wild-type B6 mice as described previ-
ously.5 Briefly, donor bone marrow cells were obtained
by flushing the femurs of GFP-transgenic or wild-type
mice with Hanks’ balanced solution. Intraperitoneal injec-
tion of 0.2 ml of the solution, containing 3 to 5 3 107 bone
marrow cells, were carried out into the mice that were
irradiated 1 day before with a sublethal dosage 8.0 or 9.0
Gy of 60Co g rays for 7-postnatal-days young and
5-week-old adult mice, respectively.
FACS Analysis
To quantify the amount of engraftment, the peripheral
blood mononuclear cells from 5-week-old chimeric wild-
type B6 mice were analyzed at 3, 4, and 10 weeks after
BMT. Briefly, the blood from the ventral tail vein was
collected in Gibson’s solution, an anti-coagulant, and the
red blood cells were lysed with a Tris-ammonium chloride
red blood cell lysis buffer. The peripheral blood mononu-
clear cells were then analyzed by flow cytometry using a
Becton-Dickinson FACScan (San Jose, CA). The leuko-
cytes were gated on and fluorescence measured under
the fluorescein isothiocyanate channel. All analysis and
quantitation were performed using the Cyclops software
from Cytomation, Inc. (Fort Collins, CO).
Tissue Preparation
A total of 15 twitcher mice and nine wild-type littermate
control mice transplanted with GFP1 bone marrow cells
were examined at 25 to 30 postnatal days (group I), 35 to
40 postnatal days (group II), and 100 to 150 postnatal
days (group III). Each group consisted of five chimeric
twitcher mice and three chimeric wild-type littermate
mice. Three additional adult GFP-transgenic mice were
also examined. The mice were anesthetized with ether
and perfused transcardially with physiological saline
(0.9% NaCl), followed by cold-buffered 4% paraformal-
dehyde. The entire brain, spinal cord, sciatic nerve, liver,
spleen, and kidney were then removed, postfixed in the
same fixative for 4 hours, and immersed in the phosphate
buffer containing 20% sucrose overnight at 4°C. Serial
sections of the cerebrum, cerebellum, brainstem, spinal
cord, liver, spleen, and kidney were cut at 40-mm thick-
ness with a vibratome. Sciatic nerves were teased gently
with fine forceps. The sections were then coverslipped
with Vectashield mounting medium for fluorescence
(Vector Laboratories, Burlingame, CA) and examined/
photographed under a Nikon microphoto FXA micro-
scope (Nikon, Garden City, NJ) equipped with a fluores-
cein isothiocyanate filter. A strong GFP fluorescence was
observed in the cell bodies and the processes in the
sciatic nerve, spleen, liver, and kidney. In the sections
from CNS, the fluorescence was somewhat weaker and
thus, sections were further immunostained with anti-GFP
antibody (Clontech) to enhance the fluorescence.
Immunocytochemistry
The brain and spinal cord sections were pretreated with
10% normal goat serum with 0.2% Triton X-100, and then
processed for single- and double-immunostaining. In
brief, all brain and spinal cord sections were incubated
with polyclonal antibody against GFP (Clontech) at a
dilution of 1:200. After washing briefly, the sections were
exposed to fluorescein isothiocyanate-conjugated goat
anti-rabbit IgG (Sigma Chemical Co., St. Louis, MO). The
immunostained sections were then examined/photo-
graphed with the microscope. Sections with or without
GFP immunostaining were further processed for Mac-1
double-immunostaining. After incubating with monoclo-
nal antibody against mouse Mac-1 (Boehringer-Mann-
heim, Indianapolis, IN) at a dilution of 1:500, the sections
were incubated for 1 hour in biotinylated anti-rat IgG and
then for 1 hour in avidin-biotin-peroxidase complex solu-
tion (Vector). After rinsing, the sections were finally re-
acted in a solution of 0.05% 3,3[hyph]diaminobenzidine
containing 0.01% H2O2 in Tris-HCl buffer (pH 7.6). The
sections were mounted and photographed again.
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Results
GFP-Transgenic Mouse
In the adult GFP-transgenic mouse (Figure 1A), ;90% of
the peripheral blood mononuclear cells are GFP1 cells.
However, in the brain, GFP1 cells were rarely detected
even after additional anti-GFP antibody immunostaining.
Very rare ramified microglia with a few long, delicate
processes and a small cell body in the fimbria hip-
pocampi and Bergmann glial cells in the cerebellum were
GFP-positive (data not shown). GFP1 cells were not de-
tected in the spinal cord and brainstem.
Bone Marrow Transplanted Wild-Type and
Twitcher Mice
In wild-type adult B6 mice transplanted with GFP-trans-
genic bone marrow at 3, 4, and 10 weeks after BMT, 65%,
70%, and 82% GFP1 peripheral blood mononuclear cells
were detected, respectively, as mean of 5 mice (Figure
1B). This demonstrates that cells from GFP-transgenic
mice can be detected in the peripheral nervous system
and provides a mean to identify and track bone marrow
derived cells in the CNS.
Clinical Course of Twitcher Mice with BMT
The untreated twitcher mice could not survive beyond 37
to 45 days of age. However, after BMT, the chimeric
twitcher mice were able to survive three to five times
longer than nonchimeric twitcher mice with reduced neu-
rological symptoms as reported previously.5 The body
weight of these chimeric twitcher mice remained less
than that of chimeric wild-type littermate mice, however.
Distribution of GFP1 Cells
Visceral Organs
Distribution of GFP1 cells in visceral organs was sim-
ilar in both chimeric twitcher and wild-type mice. In
groups I and II, almost all hematopoietic cells in the
spleen expressed GFP fluorescence (Figure 2A). In con-
trast to the rapid engraftment in the spleen, only rare
GFP1 cells were observed in the liver, kidney, and lung
(data not shown). In group III mice, an increased number
of GFP1 cells was seen in the liver (Figure 2B), kidney,
and lung (data not shown).
Peripheral Nervous System
In wild-type chimeric mice, a few slender spindle-
shaped GFP1 cells were detected along the nerve fibers
in the sciatic nerve in all three groups (data not shown).
Compared with wild-type chimeric mice, numerous GFP1
cells were observed in the sciatic nerve of the chimeric
twitcher mice in all three groups (Figure 2C). In groups I
and II, the majority of the GFP1 cells had a spheroid,
round cell body. But in group III, almost all of GFP1 cells
were slender and spindle-shaped along the nerve fibers.
Central Nervous System
Control Mice
In wild-type chimeric mice of all groups, although a few
GFP1 cells were observed in the CNS (Figure 2, J–L),
they were far less than those in other organs. They were
predominantly seen in the choroid plexus (Figure 2J),
perivascular region (Figure 2L), and leptomeninges. Most
GFP1 cells in these areas were spindle-shaped but a few
were oval.
Twitcher Mice
In group I chimeric twitcher mice, the distribution of
GFP1 cells was similar to the wild-type chimeric mice,
except for a few GFP1 cells with a round cell body which
Figure 1. Engraftment of peripheral blood mononuclear cells by GFP1 cells.
Peripheral blood mononuclear cells from 5-week-old wild-type B6 mice,
which received bone marrow cells from wild-type B6 or GFP-transgenic mice
were analyzed by flow cytometry at 3, 4 (A), and 10 weeks after BMT.
Histograms: dashed, B6 into B6; solid black, GFP-transgenic; filled gray,
B6/GFP chimera 4 weeks after MBT. Results are summarized in B.
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were detected in the white matter of spinal cord (data not
shown). In group II chimeric twitcher mice (Figure 2,
D–F), however, numerous GFP1 cells were detected in
the cerebrum especially in the white matter such as the
corpus callosum (Figure 2D), internal capsule and fimbria
hippocampi, spinal white matter (Figure 2E), and brain-
stem (Figure 2F). Only a few GFP1 cells were seen in the
cerebellum (data not shown). Most of these GFP1 cells in
the white matter had a round or spheroid cell body rem-
iniscent of ameboid cells, whereas those in the gray
matter displayed a small cell body with two or three fine
processes. In group III chimeric twitcher mice (Figure 2,
Figure 2. Photomicrographs showing the distribution of GFP1 cell in chimeric twitcher (A–I) and wild-type littermate chimeric mouse (J–L) at 35 postnatal days
(A–F) and 150 postnatal days (G–L). Nearly all cells in the spleen (A) showing green fluorescence indicate engraftment with GFP1 donor cells. B: GFP1 cells
(arrows) in the liver. In the sciatic nerve (C), many ameboid GFP1 cells (arrows) are observed. Arrows in D and E indicate ameboid cell and in I ramified
cell. Arrows in L indicate perivascular cell. CC, corpus callosum; LV, lateral ventricle; cont, wild-type littermate control mice. A–C, without GFP immunostaining.
Scale bar, 160 mm in A, B, D. E, G, H, J, K; 80 mm in F, I; and 40 mm in C, L.
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G–I), GFP1 cells were still numerous, although more cells
were detected in the white matter in the cerebrum (Figure
2G). Compared with group I and II chimeric twitcher
mice, GFP1 cells were more ubiquitously distributed in
both the gray and white matter, in particular, in the spinal
cord (Figure 2H). The majority of them had two or three
fine processes with a small cell body, although few ame-
boid cells were still observed. At this time point, the
increased number of GFP1 cells with both ameboid and
ramified form were observed in the cerebellum (Figure
2I). The double-immunostaining with Mac-1 antibody
showed that more than 50% GFP1 cells in the group II
chimeric twitcher mice expressed immunoreactivity with
Mac-1 (Figure 3A). In group III, almost all of GFP1 cells
with fine processes were double-immunostained with
Mac-1 (Figure 3, B and C)
Discussion
In agreement with the previous work,20,21 our study has
shown that in the wild-type chimeric mice, the engraft-
ment of splenic monocytes/macrophages takes place
rapidly within a month and slower in the lung, kidney,
liver, and brain. The distribution of the donor cells in the
CNS was predominantly seen at the perivascular and
leptomeningeal, and not parenchymal sites. In the chi-
meric twitcher mice, distribution of the donor cells in the
visceral organs is similar to that of wild-type littermate
chimeric mice. In the nervous system, however, signifi-
cant numbers of the infiltrated donor cells were detected
in the chimeric twitcher mice older than 35 postnatal days
in groups II and III. The majority of GFP1 ameboid cells
with large cell bodies, suggestive of an activated status,
noted in the group II chimeric twitcher almost disap-
peared in the group III chimeric twitcher mice that sur-
vived longer than 100 days. In these long-surviving chi-
meric twitchers, the majority of GFP1 cells resembled
ramified microglia with small cell body and fine delicate
cellular processes. The morphological difference of
GFP1 cells in these two groups suggests that transfor-
mation of activated ameboid cells of hematogenous ori-
gin to reposition themselves as quiescent ramified micro-
glia. Our preliminary study showed the presence of
numerous Ia- and CD8-immunoreactive ameboid cells
and increased tumor necrosis factor-a and interleukin-10
mRNA by reverse transcriptase-polymerase chain reac-
tion determination in the group II twitcher mice but such
increase in the immunoreactivity or mRNA was not found
in the group III twitcher mice. These data are also con-
sistent with the transformation of macrophages/microglia
from active to the quiescent state. Although some of the
donor cells were not marked by the Mac-1 antibody at the
beginning of the infiltration, eventually they became ram-
ified cells and labeled by the Mac-1 antibody. It might
suggest, therefore, that some undifferentiated donor cells
also infiltrated into the demyelinating CNS of twitcher
mice.
The twitcher mouse is a model of GLD in humans that
is caused by the mutation of the galactosylceramidase
gene. The disease is characterized pathologically by an
apoptotic death of oligodendrocytes,22 diffuse demyeli-
nation, and a massive increase of the reactive microglia/
macrophages in the CNS and peripheral nervous sys-
tem.23,24 The demyelination progressed in orderly
fashion and affected the peripheral nervous system ear-
lier than the CNS.25,26 The reactive microglia/macro-
phages are detected in the spinal white matter at 20
postnatal days and in the cerebral white matter at 25
postnatal days in twitcher mice. In chimeric twitcher
mice, however, GFP1 cells were detected in the CNS
only after 35 postnatal days. Although these twitcher
mice received irradiation before BMT, this apparently
delayed response of hematogenous macrophage infiltra-
tion in chimeric twitcher mice is not because of irradia-
tion, because our study with intraperitoneal injection of
rhodamine in nonirradiated twitcher mice resulted in de-
layed cellular infiltration similarly (Y-P Wu, J Matsuda,
A Kubota, K Suzuki, and K Suzuki, unpublished observa-
tion). We hypothesize that the delayed response may be
explained as follows; in the early stage of demyelination,
phagocytosis of myelin debris is carried out primarily by
local activated microglia. These activated microglia syn-
thesize and secrete a variety of proinflammatory, poten-
tially cytotoxic cytokines, such as tumor necrosis factor-a
and interleukin-1.27–31 Infiltration of the peripheral hema-
togenous cells may take place in response to these cy-
tokines and/or various chemokines. Thus, the pattern of
donor cell infiltration in the twitcher mice in the current
study seems to follow this naturally occurring demyelinat-
ing process and is totally different from the pattern of
Figure 3. Photomicrographs showing GFP-positive cells double-immunos-
tained with Mac-1 in corpus callosum of 35 postnatal days (A) and cerebel-
lum of 150 postnatal days (B and C) chimeric twitcher. Arrows in A indicate
GFP (green) and Mac-1 (brown) double-positive cells and arrowheads
indicate cells expressing GFP only (green). Asterisk in A indicates a Mac-1
positive microglia. The black arrows in B and white arrows in C indicate
the Mac-1/GFP double-positive ramified microglia. The arrowheads in B
indicate cells immunostained with Mac-1 only. A: without GFP immunostain-
ing. Scale bar, 20 mm in A and 40 mm in B and C.
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donor cell infiltration seen in the murine model of Sand-
hoff disease, in which the major pathology is a neuronal
storage and peripheral hematogenous cells are detected
mostly in the gray matter.15 Thus, natural disease pro-
cess seems to determine the site and extent of hematog-
enous cell infiltration and eventual effectiveness of the
BMT treatment. Our study also indicates that unlike rapid
splenic engraftment, cellular infiltration into the CNS is a
slow process because very few GFP1 cells were de-
tected within the CNS of chimeric twitcher mice younger
than 35 postnatal days. This slow process may explain
the ineffectiveness of BMT on the rapidly progressive
infantile form of GLD, although BMT seems effective as
the treatment of late onset slowly progressive form of
GLD.3
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